180 related articles for article (PubMed ID: 23884069)
21. Prisons and HCV: a review and a report on an experience in New South Wales Australia.
Batey RG; Jones T; McAllister C
Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530
[TBL] [Abstract][Full Text] [Related]
22. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
[TBL] [Abstract][Full Text] [Related]
23. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
Khaw FM; Stobbart L; Murtagh MJ
BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
[TBL] [Abstract][Full Text] [Related]
24. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
[TBL] [Abstract][Full Text] [Related]
25. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Charlebois A; Lee L; Cooper E; Mason K; Powis J
J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C in Israeli prisons: status report.
Michaeli N; Litvin A; Davidovitch N
Harm Reduct J; 2020 Oct; 17(1):79. PubMed ID: 33076926
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C in prison settings: screening and therapy are improving. Comparative survey between 2000 and 2003].
Remy AJ;
Presse Med; 2006 Sep; 35(9 Pt 1):1249-54. PubMed ID: 16969313
[TBL] [Abstract][Full Text] [Related]
29. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
[TBL] [Abstract][Full Text] [Related]
30. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
[TBL] [Abstract][Full Text] [Related]
31. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting.
Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C;
Int J Drug Policy; 2020 Mar; 77():102693. PubMed ID: 32045828
[TBL] [Abstract][Full Text] [Related]
32. HCV micro-elimination in two prisons in Milan, Italy: A model of care.
Giuliani R; Casigliani V; Fornili M; Sebastiani T; Freo E; Arzilli G; Scardina G; Baglietto L; Tavoschi L; Ranieri R
J Viral Hepat; 2020 Dec; 27(12):1444-1454. PubMed ID: 32815623
[TBL] [Abstract][Full Text] [Related]
33. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
34. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
35. A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.
Nguyen JT; Rich JD; Brockmann BW; Vohr F; Spaulding A; Montague BT
J Urban Health; 2015 Aug; 92(4):635-49. PubMed ID: 25828149
[TBL] [Abstract][Full Text] [Related]
36. A framework for management of hepatitis C in prisons.
Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
[TBL] [Abstract][Full Text] [Related]
37. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
[TBL] [Abstract][Full Text] [Related]
38. Mental health consultations in a prison population: a descriptive study.
Kjelsberg E; Hartvig P; Bowitz H; Kuisma I; Norbech P; Rustad AB; Seem M; Vik TG
BMC Psychiatry; 2006 Jun; 6():27. PubMed ID: 16759383
[TBL] [Abstract][Full Text] [Related]
39. [Screening and treatment of hepatitis C virus in prisons: 10 years of experience].
Werling K; Makara M; Nemesi K; Horváth G; Schneider F; Bali I; Enyedi J; Jancsik V; Káfony A; Lesch M; Lombay B; Müller Z; Ozsvár Z; Patai Á; Péterfi Z; Pusztay M; Szabó O; Szlávik J; Tóth T; Varga M; Gács J; Újhelyi E; Nemes Nagy A
Orv Hetil; 2022 May; 163(22):871-878. PubMed ID: 35895613
[TBL] [Abstract][Full Text] [Related]
40. "That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison.
Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR
Int J Drug Policy; 2022 Jan; 99():103456. PubMed ID: 34560624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]